S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
Log in

Loncar Cancer Immunotherapy ETF News Headlines (NASDAQ:CNCR)

$23.38
-0.04 (-0.17 %)
(As of 12/5/2019 04:00 PM ET)
Add
Today's Range
$23.35
Now: $23.38
$23.78
50-Day Range
$18.52
MA: $20.93
$23.61
52-Week Range
$16.87
Now: $23.38
$23.78
Volume8,839 shs
Average Volume9,850 shs
Market Capitalization$38.58 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Headlines

Loncar Cancer Immunotherapy ETF (NASDAQ CNCR) News Headlines

Source:
DateHeadline
A Guide to Biotech ETF InvestingA Guide to Biotech ETF Investing
finance.yahoo.com - December 2 at 5:05 PM
Investing In The Holy Grail Of Cancer Treatment: ImmunotherapyInvesting In The Holy Grail Of Cancer Treatment: Immunotherapy
seekingalpha.com - November 22 at 5:36 PM
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTDHealthcare Sector Outperforming: 5 Best ETFs & Stocks QTD
finance.yahoo.com - November 21 at 1:01 PM
Cancer-Fighting Stocks & ETF: What You Need to KnowCancer-Fighting Stocks & ETF: What You Need to Know
www.nasdaq.com - June 5 at 5:59 PM
Why Cancer-Fighting Stocks & ETFs Are SoaringWhy Cancer-Fighting Stocks & ETFs Are Soaring
finance.yahoo.com - June 3 at 5:49 PM
Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain OutlookHealthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook
finance.yahoo.com - March 8 at 6:24 PM
Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled forBristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for
www.nasdaq.com - January 2 at 9:23 AM
Loncar China BioPharma ETF (CHNA) Launches on NasdaqLoncar China BioPharma ETF (CHNA) Launches on Nasdaq
finance.yahoo.com - August 15 at 9:37 AM
Biotech ETFs Go Under the MicroscopeBiotech ETFs Go Under the Microscope
finance.yahoo.com - April 12 at 10:24 AM
Cancer-Focused ETF Tops the ChartsCancer-Focused ETF Tops the Charts
www.wsj.com - April 9 at 9:46 AM
3 Sector ETFs That Gained Double-Digits in Q13 Sector ETFs That Gained Double-Digits in Q1
finance.yahoo.com - March 28 at 4:22 PM
Here's an ETF to Invest in Immunotherapy--the Game Changing Cancer TreatmentHere's an ETF to Invest in Immunotherapy--the Game Changing Cancer Treatment
finance.yahoo.com - March 16 at 5:22 PM
The 10 Best ETFs of February 2018The 10 Best ETFs of February 2018
finance.yahoo.com - March 8 at 9:54 AM
4 Market-Beating Sector ETFs & Stocks of February4 Market-Beating Sector ETFs & Stocks of February
www.zacks.com - February 28 at 9:28 AM
This Feel Good ETF Is A Top ETF Performer This YearThis 'Feel Good' ETF Is A Top ETF Performer This Year
seekingalpha.com - February 27 at 5:00 PM
Biotech ETF (CNCR) Hits New 52-Week HighBiotech ETF (CNCR) Hits New 52-Week High
www.zacks.com - February 20 at 9:08 AM
Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under ManagementLoncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management
finance.yahoo.com - February 16 at 9:11 AM
5 Best-Performing Stocks of the Top ETF of January5 Best-Performing Stocks of the Top ETF of January
www.zacks.com - January 31 at 9:20 AM
Loncar Cancer Immunotherapy Index Conducts Semi-Annual RebalanceLoncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
finance.yahoo.com - December 20 at 8:44 AM
Loncar Cancer Immunotherapy Index Announces Merger ReplacementsLoncar Cancer Immunotherapy Index Announces Merger Replacements
finance.yahoo.com - November 3 at 10:29 AM
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Featured Article: What is the CAC 40 Index?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel